NIV Mask and Headgear Evaluation

Non-invasive ventilation (NIV) is a method of providing artificial respiratory support without placement of a tube in the airway; the air pressure is applied externally through the nose and/or the mouth. NIV was developed in the 1980s to support breathing in children with nocturnal hypoventilation due to neuromuscular weakness. In recent years the use of NIV has been offered to an extended group of patients with acute and chronic respiratory failure. The aims of NIV are to improve gas exchange and to improve respiratory symptoms. Without ventilation, these patients will suffer chronic hypoxia resulting in pulmonary hypertension, cor pulmonale and premature death. NIV is effective in correcting nocturnal hypoventilation and in alleviating the associated symptoms. There is evidence that the use of NIV improves the quality of life in children with neuromuscular disorders and the life expectancy with those who decline NIV being more likely to die of respiratory failure within 2 years (6-12). NIV has been shown to reduce both hospital admissions (2-4 per year pre-NIV and 1 per year post-NIV) and days spent in hospital (40-50 per year pre-NIV and 10 per year post-NIV). Further work to look at this is underway within our group. The biggest challenge with NIV treatment is enabling the child to tolerate the interface; the biggest cause of failure of NIV is the inability to fit a comfortable mask. Air leaks around the mask due to poor fit are a common reason for NIV to be ineffective and to be poorly tolerated. Pressure from an NIV mask on the growing face can result in under-development of the maxilla, leading to mid-face flattening and mal-occlusion of the teeth after as little as 4 weeks. Breakdown of the skin and pressure sores, usually on the bridge of the nose or forehead can occur when using mask ventilation. Prevention is better than cure and can be achieved if a suitably fitting mask is available. NIV masks are available commercially for standard-size adults and children, but a good fit can be difficult to obtain in children with facial dysmorphic syndromes and other underlying co-morbidities. Custom-made masks are associated with a lower incidence of skin injury but are not available in most UK centres. The COMFORT project has developed a prototype custom made mask as well as a modular headgear prototype using 3D scanning and printing technology. Further work is taking place to inform the optimal 3D scanning technique and a software algorithm to automate the design process. This pilot clinical study will gain data in order to inform a multicentre clinical trial.